ARCHIVES

Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center

This article is from The Cancer Letter archive.

Vol. 24 No. 47 | December 11, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: Michael Grever Named DCT Deputy Director; MSK’s Burton Lee New White House Physician

March 31, 1989

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

July 29, 2011

CCOP Letters Of Intent Reach 232; Frelick Experts 80-90 Percent Of them To Qualify For Applications

September 3, 1982

Administration Seeks Authorization Bill Repealing National Cancer Act, Other NIH Special Authorities

March 8, 1985

Advisory Council To Be Named For Alternative Medicine Cuts

May 27, 1994